Should-alpha-interferon be included as standard treatment in multiple myeloma?
Ludwig
H
H
1st Department of Medicine and Oncology, Wilhelminenspital, Vienna, Austria.
Fritz
E
E
Zulian
G B
GB
Browman
G P
GP
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001294:Attitude to Health; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D009101:Multiple Myeloma / Q000628:therapy*; D017060:Patient Satisfaction; D010865:Pilot Projects; D016032:Randomized Controlled Trials as Topic
D000970:Antineoplastic Agents; D016898:Interferon-alpha